Cognito Therapeutics patented gamma sensory stimulation technology that reduces white atrophy
The developers claim that the patentedGamma sensory stimulation at 40 Hz for six months reduces white matter atrophy in patients with Alzheimer's disease and may also protect axons and possibly prevent damage to myelin and oligodendrocytes.
Cognito Therapeutics plans to start trials to confirm the device's clinical effectiveness as early as this year.
More from the site
Revealed the price of a smartphone LG with a rotating screen
Good-old Moto 360 smartwatch is back - with new hardware and a $ 350 price tag
On day 3 of illness, most COVID-19 patients lose their sense of smell and often suffer from a runny nose
Indian probe "Chandrayan-2" confirmed the presence of water molecules on the moon
The developers of Gothic Remake congratulated gamers on Christmas holidays and showed a screenshot of the updated game
Biologists have discovered a supergroup of ancient "toothy" predators
120 Hz AMOLED screen, MediaTek Dimensity 8200 chip and 50 MP triple camera: an insider told what the vivo S16 Pro smartphone will be like
How Eco-Friendly Are Electric Scooters Really? All ecological transport problems